GlassScriptPhysician profile
Shaun Conley
NPI 1528412491
$14,504.23
in general payments reported to CMS, 2019-2025
9 companies · $1,448 in 2025
The $1,448 reported for 2025 was more than what 77% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $18.73 · 2021: $15.57 · 2022: $2,072 · 2023: $189 · 2024: $91.60 · 2025: $1,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $981 · Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $981.21 |
| Food and Beverage | $746.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $10,635.38 | 2019 | |
| Nuvasive, INC. | $2,072.05 | 2022 | |
| Elite Orthopedics, LLC | $1,461.57 | 2023-2025 | |
| Arthrex, INC. | $219.95 | 2025 | |
| Medtronic, INC. | $48.34 | 2021-2024 | Unid_pass |
| Acera Surgical, INC. | $18.73 | 2020 | |
| Acumed LLC | $17.69 | 2019 | |
| Stryker Corporation | $16.67 | 2019 | |
| Integra Lifesciences Corporation | $13.85 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaun Conley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.